# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.jcapitalresearch.com/index.html
2024 Financial Outlook"Based on our solid first quarter financial performance and our expectations for stronger revenue gro...
Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 ...
Company to repurchase all of Founder's 18.4 million shares at $4.17 per sharebiote Corp. (NASDAQ:BTMD) ("Biote" or ...
Roth MKM analyst George Kelly reiterates Biote (NASDAQ:BTMD) with a Buy and raises the price target from $8 to $9.
Previously, Biote projected fiscal 2024 revenue of greater than $200 million and Adjusted EBITDA of greater than $60 million. F...
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 pe...